In addition to MET gene amplification or mutation, MET overexpression in NSCLC and other cancer types may also be caused by transcriptional/post-transcriptional/post-translational mechanisms [12,32,57,59,60,61]. The gene discussed is MET; the disease is non-small cell lung carcinoma.